Conference Information

Welcome Message

We exuberantly welcome and invites all the delegates, speakers, exhibitors, sponsors and other participants from across the globe to participate in the 5^th International Conference on Vascular Dementia which is scheduled to be held from July 06-07, 2020 as an Online Event conducted through webinar

The conference has been placed along meticulously to fulfill the ennobling standards of our attendees and thus provides a felicitous forum that ensures interactive congregation of knowledge and intellect regarding the path-breaking researches on Vascular Dementia being conducted across the world.

Our aim is to spur the progress of efforts to explain the untouched science behind the mystery of Vascular Dementia, their mechanism, diagnosis, treatment and management inclusive of an active colloquy about the recent advances in the realm of Vascular Dementia.

The conference will extend a platform for multidisciplinary exchange of information to battle Vascular Dementia and shed light on the most sought after scientific discoveries in all its aspects. It will not only help you expand your horizon for associating with colleagues from across the world but it also comes with a well-designed program with sessions which impart the scope for discussion of cutting-edge researches in this field.

You would want to look forward to

Exceptional keynote speeches
Enlightening plenary lectures
Informatory poster and video presentations
Enriching workshops
Productive exhibitions

Who should attend:

Neurologists, Neuroscientists, Neurosurgeons, professors, doctors, research scholars and students. Business professionals and CEO’s and R&D Heads of industries are promised a very productive experience in expanding your network as well as resources. We welcome anyone who would like to make the best out of this amazing networking opportunity.

We would once again like to convey our heartiest welcome to the 5^th International Conference on Vascular Dementia and eagerly look forward to seeing you in Online event!

Sessions

Session on: Vascular Dementia and Stroke

Vascular Dementia is caused by problems with the supply of blood flow in the brain. Typically, it leads to minor strokes and heart diseases. There will be some changes in the brain structures when the Cerebrovascular disease occurs in the body and leads to strokes and lesions and resulting changes in cognition Vascular Dementia 2020 goal is to gather people to discuss the types of Vascular Dementia and describe the possibilities.

16th International conference on Dementia and Alzheimer Disease, February 10-11, 2020 Sydney, Australia; 12th International Conference on Vascular Dementia, March 13-14, 2020 Prague, Czech Republic; 16th International Conference and Exhibition on Alzheimers Disease, Dementia & Ageing, April 13-14, 2020, London, UK; 16th world congress on Vascular Dementia and Neurodegenerative Diseases May 18-19, 2020 Osaka,Japan; 13th International Conference on Dementia and Vascular Dementia, June 24-25, 2020 Zurich, Switzerland; 14th World Congress on Advances and Innovations in Dementia August 26-27, 2020 Singapore;

Session on: Causes and Prevention of Dementia

Vascular Dementia will reduce their ability to supply the required amount of oxygen and nutrition in the brain to perform thought process effectively. It mainly damages the brain’s blood vessels. Vascular Dementia includes the strokes that block the brain artery usually cause a range of symptoms. The narrowed or chronically damaged brain blood vessels are also can lead to Vascular Dementia.

The health of your brain’s blood vessels is closely linked to the overall control of heart health. Keeping your heart healthy may also help to reduce the risk of Vascular Dementia. Thus, Vascular Dementia 2020 is helping to discuss the prevention and causes of Vascular Dementia.

Session on: Vascular Cognitive Impairment

Vascular Cognitive Impairment is caused by the ailment that damages the brain’s blood vessels and refuses in thinking abilities. Vascular disease may origin Cognitive Impairment on its individual and can subsidize to Impairments in thinking and behaviour in a person with another brain disease like Alzheimer’s. The Vascular Dementia 2020 helps to describe the consequences of Vascular Cognitive Impairment .

Session on: Alzheimer’s disease

Alzheimer’s is a neurological cerebrum issue. This Alzheimer’s sickness is the most widely recognized type if dementia, the gathering of scatters that will disable the mind working. Memory loss is the most punctual indications for this disease, reduces the thinking capacities and changes in identity or contact. Thus, Vascular Dementia 2020 may give helpful focuses to the Alzheimer’s sickness and detail part of neurological science.

Session on: Aging and Dementia

Age-related memory impairment and dementia can be stated apart in several ways. Also, in adults younger than 60 will be affected rare with dementia, but dementia becomes increasingly common after 60 ages. Understanding the back-and-forth between psychology and brain changes is a vital step in the direction of improving how we age and auxiliary to healthy ageing in society. The Vascular Dementia 2020 aims to describe how our inward lives changes as we age, both as healthy and disease.

Session on: Dementia Stages

Vascular brain changes often coexist with changes linked to other types of dementia, including Alzheimer's disease and dementia with Lewy body ’s. The stages incorporate early dementia, moderate dementia, and advanced dementia. The Vascular Dementia 2020 aims to prevent and effectively treat Alzheimer’s and related dementias .

Session on: Frontotemporal Dementia

Frontotemporal dementia refers to the brain disorder mainly caused by the degeneration of the front or temporal lobes of the brain. This area is generally associated with personality, behaviour, and language.

Session on: Vascular Dementia Nursing

At present there is no cure for dementia, the emphasis of the treatment is to slow down the progression of the disease and empower them with dementia to live well. A person with dementia may brawl to maintain their individuality. They may lose self-assurance. Therefore, it is important for the carers to support the person with dementia to focus on their aims rather than focusing on what they can no longer achieve. However, Vascular Dementia 2020 will help to discuss the progression towards caring.

Session on: Advance Drug for Dementia

There are very few drugs for the management of dementia, such as Cholinesterase inhibitor (Memantine, Galantamine) and an n-cholino receptor which is used to treat the common types dementias like Alzheimer disease & dementia and Vascular Dementia and Parkinson’s disease. Also, these drugs will have an improvement in cognition. Further, this includes Neuroprotective drugs such asnimodipine, propentofylline, and posatirelin presently under study and these may be useful for Vascular Dementia. The Vascular Dementia 2020 also focuses on the advanced drugs for the treatment of Vascular Dementia.

Session on: Advances in Dementia Diagnosis

A diagnosis of dementia entails that at least two core mental purposes be lessened enough to affect with daily existing. Cognitive and Neuropsychological tests can be used to measure thinking skills. The memory treatment has been designated great significances for patients with dementia. The neurological evaluation is the treatment for problem-solving, visual perception and movement. Brain scans are like CT or MRI and PET scans are shows the patters of the brain activity if the amyloid protein had been deposited in the brain. The Conference on Vascular Dementia 2020 has taken one segment closer to dementia therapy.

Session on: Dementia Care Management

Dementia care management has been provided for 6 months at the homes of dementia patients. It is a model of concerted care, also is defined as a complex intervention to provide an optimal treatment and care for the patients. Dementia care management has been targeted at the specific patient level and has been directed by 6 study nurses with dementia care qualifications.

Session on: Animal Model and Translational Medicine

The study was established on a mouse model of Vascular Dementia to overcome the shortcomings of rat models of Vascular Dementia, which include high production costs, difficult surgery, surgical trauma and high mortality. In this study, repeated ischemia-reperfusion of the total bilateral carotid artery in mice, combined with a reduction of blood pressure, was used to establish an animal model of Vascular Dementia.

According to the study, a total of 40 Kunming mice were randomly divided into a sham group and a model group. Behavioural tests were performed for each group, and the morphology of the hippocampus was examined. All over the examinations were confirmed that the following surgery, learning and memory dysfunction was significantly increased in the model group.

The results of the morphological observations showed that the number of hippocampal CA1 neurons was significantly decreased in the model group compared with that in the sham surgery group.

This study was concluded that a mouse model of Vascular Dementia was successfully established, which was simple, effective and reliable, and may be used in the future to investigate Vascular Dementia.

Session on: Potential Future Interventions

According to the research, the estimated the burden of late-onset dementia in the UK over 2025 and weigh the impact of potential interventions. The compute infirmity adjusted life years over 2025 and consider 3 interventions, all assumes launched in 2018; an expectant restrictive case of a 100% preventive intervention with instant uptake of 100% of the population at risk; an intervention which delays onset by 5 years, linear uptake to 50% after 5 years; but uptake 75% after 5 years.

By 2025, the disability-adjusted life years burden will have increased by 42% from the Global Disease Burden 2010 as estimated. Intervention results: some 9% decreases by 2025; a 33% increases; and a 28% increases.

Market Analysis

Around 900 million people are aged 60 years and over living worldwide. Rising life expectancy is contributing to rapid increases in this number and is associated with increased prevalence of chronic diseases like Vascular Dementia.

Globally, consequences of a current meta-evaluation endorse that 44 million human beings lived with Vascular Dementia worldwide in 2010, with numbers predicted to nearly double every 20 years, to 65.7 million in 2030 and 115.4 million in 2050. In 2010, 58 percent of everyone with Vascular Dementia lived in international locations with low or middle earning, with this proportion expected to upward push to 63 percent in 2030 and 71 percent in 2050. This wide variety is anticipated to double with the aid of 2030 and greater than triple with the aid of 2050 to 115 million

In line with the observed, the meta-evaluation accounts for 109,952 older people ‘at hazard’, and it's far representing 332,323 individual-years of follow-up. The Western European examine indicates 42% of the full individual-years, 24% of the people in North American, the East Asian examine indicates 16%, and the Latin American examine indicates 13%. just 5% of people are contributed by means of the research from Australasia, Asia Pacific, South Asia, and sub-Saharan Africa blended.

It’s estimated that around 8,50,000 people are living with Dementia in the UK and around 1,50,000 people have Vascular Dementia.

Although Vascular Dementia predominantly disturbs people over the age of 65, around 40,000 living with the disorder in the UK are younger. Another common delusion regarding Dementia is that it is a singular illness or disease.

According to research If global Vascular Dementia care were a country, it would be the 18th largest economy in the world. The market values of companies like Apple (the US $742 billion) and Google (the US $368 billion) are exceeded annually.